Do I Have an STD? Symptoms and When to Test

Most sexually transmitted infections produce no symptoms at all, which means the question “Do I have an STD?” almost never has a reliable answer based on how you feel. Research estimates that roughly three-quarters of chlamydia cases and close to half of gonorrhea cases never cause noticeable symptoms.¹ That single fact reshapes the entire conversation: testing, not symptom-watching, is the only way to know your status with any confidence.

Why Symptoms Are an Unreliable Guide

The idea that you would “know” if you had an STI is one of the most persistent and damaging misconceptions in sexual health. The numbers tell a different story. An estimated 77% of chlamydia infections and 45% of gonorrhea infections never produce symptoms. Among untreated cases of both infections, the overwhelming majority went untreated specifically because the person never felt anything wrong.¹ Trichomoniasis, often overlooked in routine screening, is also frequently silent in both men and women.² Herpes can shed virus without active sores. HPV can linger for years with no visible warts. HIV has a brief flu-like window that many people either miss or attribute to something else.

The practical takeaway is straightforward: if you are sexually active and have had unprotected contact, or if a partner has been diagnosed with something, you should test regardless of how you feel. Waiting for symptoms means waiting for damage that could have been prevented.

Symptoms Worth Recognizing When They Do Appear

Even though many infections stay silent, some do announce themselves. Knowing the common signs helps you act quickly when they show up, and helps you understand what a clinician is looking for.

Chlamydia and Gonorrhea

When these bacterial infections do cause symptoms, they tend to appear within one to three weeks of exposure. In people with a cervix, the signs can include unusual vaginal discharge, bleeding between periods, and pain during urination. In people with a penis, symptoms are more often noticeable: a burning sensation while urinating and a discharge from the urethra. But these infections do not limit themselves to the genitals. Rectal and throat infections are common and frequently asymptomatic, even when the person has not reported the specific sexual behaviors that would suggest exposure at those sites.³ A rectal infection might cause mild discomfort or discharge, or it might cause nothing at all. A throat infection rarely causes noticeable symptoms.

Syphilis

Syphilis moves through stages, each with a different look. The first sign is usually a painless sore, called a chancre, appearing at the site of contact anywhere from 10 to 90 days after exposure. It can show up on the genitals, in the mouth, or elsewhere. Because the sore is painless and sometimes hidden inside the vagina or rectum, many people never notice it. It heals on its own in two to six weeks, which gives a false sense of resolution.⁴

Four to eight weeks after the chancre appears, secondary syphilis can develop. This stage brings a body-wide rash that often appears on the palms of the hands and soles of the feet, along with low-grade fever, swollen lymph nodes, headache, and general fatigue.⁴ Oral symptoms during this stage are also well documented.⁵ If untreated, syphilis enters a latent phase with no symptoms at all, and can eventually progress to cause serious damage to the heart or nervous system years later.

Genital Herpes

A first herpes outbreak tends to be the most severe and can include painful blisters or ulcers in the genital or anal area, along with flu-like symptoms such as fever and body aches. After that initial episode, the virus stays in the body and can reactivate periodically. Whether that first episode is truly “primary” (meaning you have never been exposed to any form of herpes simplex virus before) or “nonprimary” (you already carry antibodies from a prior exposure to a different herpes type) affects how the infection behaves going forward.⁶ Many people with herpes have very mild or no noticeable outbreaks and can shed virus without knowing it.

HPV

Human papillomavirus is extremely common and almost always invisible. Low-risk strains can cause genital warts, which are flesh-colored bumps that may be flat or raised. High-risk strains are the ones linked to cervical cancer and other cancers, and they produce no warts or other outward signs. The only way they are typically detected is through screening tests like Pap smears or HPV-specific tests.⁷ Most HPV infections clear on their own within a couple of years, but the high-risk strains that persist are the ones that require monitoring.

HIV

Acute HIV infection can produce symptoms that look a lot like a bad flu or mono: fever, sore throat, rash, swollen lymph nodes, diarrhea, and fatigue. In one community-based screening program, about half of people diagnosed with acute HIV reported ongoing symptoms at the time of their test, and another quarter reported recent symptoms in the two weeks prior.⁸ A larger study found fever was present in about 93% of acute HIV cases, followed by fatigue, sore throat, skin rash, and swollen lymph nodes.⁹ The problem is that these symptoms are identical to many common viral illnesses, so they are routinely dismissed. After this acute phase passes, HIV can remain without symptoms for years while progressively damaging the immune system.

Timing Matters More Than You Think

Every STI test has a “window period,” the gap between when you are exposed and when a test can reliably detect the infection. Testing too soon can produce a false negative, giving you false reassurance while you are actually infected and potentially contagious.

For HIV, this window depends on the type of test. Laboratory-based tests that detect both antigen and antibody can pick up infection as early as about six days after exposure on average, and nearly all infections are detectable by around 44 days. Older tests like the Western blot have a longer window, with the 99th percentile stretching to about 65 days.¹⁰ Rapid finger-prick tests that detect only antibodies fall somewhere in between. If you had a specific high-risk exposure, a negative result taken within days means very little. For chlamydia and gonorrhea, most guidelines suggest waiting at least one to two weeks after exposure for nucleic acid tests to be accurate. For syphilis blood tests, the window can be several weeks to a few months.

The practical rule: if you are testing after a specific known exposure, ask your provider when the earliest reliable test can be done, and consider retesting after the full window has closed.

What Modern STI Testing Actually Looks Like

The backbone of chlamydia and gonorrhea testing today is a type of test called a nucleic acid amplification test, or NAAT. These tests detect small fragments of bacterial DNA or RNA and are far more sensitive than the older approach of growing bacteria in a culture dish. One head-to-head comparison found that NAAT detected a large number of chlamydia infections that culture missed entirely, and the difference in sensitivity was highly significant.¹¹ For gonorrhea specifically, NAAT sensitivity has been measured at close to 99%, compared with about 86% for traditional culture.¹²

These tests can be run on a urine sample, a vaginal swab, a cervical swab, or swabs from the throat and rectum. Vaginal swabs perform comparably to cervical and urine specimens for detecting both chlamydia and gonorrhea, with performance above 80% in virtually all studies evaluated.¹³ Syphilis and HIV are detected through blood tests. Herpes testing involves either swabbing an active sore or, in the absence of symptoms, a blood test looking for antibodies, though herpes blood tests have well-known limitations in accuracy that make routine screening controversial.

Why a Urine Sample Is Not Always Enough

If you have had oral or anal sexual contact, a standard urine test or genital swab will miss infections at other sites. Chlamydia and gonorrhea can live in the throat and rectum independently of any genital infection. Among women who reported oral or anal exposures, about 30% of all gonorrhea cases and roughly 14% of all chlamydia cases would have been missed entirely if only genital testing had been performed.¹⁴ The data for men who have sex with men show similar patterns of isolated extragenital infections.

Rectal sites have particularly high positivity rates for both chlamydia and gonorrhea, and these infections are often found even without reported receptive anal intercourse.¹⁵ This matters because an untreated rectal or throat infection can be passed to partners and can serve as a reservoir for reinfection even after genital treatment. When you are tested, be honest with your provider about the types of sexual contact you have had so they can order the right swabs. If the conversation feels uncomfortable, remember that the clinician’s only goal is making sure nothing gets missed.

Home Collection Kits and Self-Swabs

The availability of home STI testing has expanded substantially. For chlamydia and gonorrhea, self-collected vaginal swabs and urine samples taken at home show high agreement with samples collected in a clinic. A systematic review and meta-analysis found concordance rates above 96% for chlamydia across vaginal swabs, urine, and pooled specimens collected at home versus in the clinic. For gonorrhea, concordance reached 100% for urine and pooled specimens.¹⁶

Extragenital self-collection, meaning rectal and throat swabs you do yourself, is newer but also performs well. A validation study comparing self-collected rectal and throat swabs to provider-collected ones found positive agreement ranging from about 91% to 100%, and the self-collected swabs actually picked up a few additional positive cases the provider swabs missed.¹⁷ Home kits are not a replacement for a clinical relationship, especially if you need treatment, but they remove a significant access barrier for people who find clinic visits difficult to schedule or uncomfortable to attend.

After a Positive Result

A positive test for a bacterial infection like chlamydia, gonorrhea, or syphilis means antibiotic treatment, usually straightforward and highly effective. But treatment alone is not the end of the process. Retesting after treatment matters, because reinfection is common. For chlamydia, research suggests that about eight weeks after treatment is an effective time to retest, balancing the likelihood that people actually return for the follow-up with the need to catch reinfections early.¹⁸ Testing too soon after treatment can sometimes pick up dead bacterial DNA and produce a false positive, while waiting too long gives a new infection time to cause complications or spread to a partner.

Partner notification is the other critical piece. If your sexual partners are not informed and treated, the infection can bounce back and forth. Expedited partner therapy, where the diagnosed person delivers medication directly to their partner without the partner needing their own clinic visit, has been modeled to substantially reduce reinfection. One modeling study estimated that providing this approach to just 20% of people diagnosed with chlamydia or gonorrhea could prevent about 27% of expected infections over a decade.¹⁹ Many states allow this practice, and your provider can tell you whether it is an option.

How One STI Changes the Risk of Another

STIs do not exist in isolation. Having one active infection can make you more vulnerable to acquiring others. The relationship between herpes (HSV-2), syphilis, and HIV is the best-studied example. Both herpes sores and syphilitic lesions cause changes in the tissue that increase the number of immune cells HIV targets, creating a biological welcome mat for the virus.²⁰ This means that treating and preventing other STIs is itself a form of HIV prevention. It also means that a diagnosis of one infection should prompt testing for others, not because they always travel together, but because the conditions that led to one exposure often overlap with conditions for another, and the biology of co-infection compounds the risk.

Doxycycline as Post-Exposure Prevention

A newer development in STI prevention is doxycycline post-exposure prophylaxis, sometimes called doxy-PEP. The concept is simple: taking a dose of the antibiotic doxycycline within 72 hours after unprotected sex to reduce the chance of acquiring bacterial STIs. A real-world study at an urban STD clinic found that people taking doxy-PEP experienced a roughly 60% reduction in any new STI, with particularly strong reductions in chlamydia and gonorrhea.²¹ Current guidance generally targets this approach toward men who have sex with men and transgender women who are at elevated risk, though the conversation around broader use is evolving. One concern is that widespread antibiotic use could accelerate resistance, particularly in gonorrhea, which already has a track record of developing resistance to multiple drug classes. This is an area where individual benefit and public health considerations are in some tension, and the science is still catching up with the practice.

Stigma and the Testing Gap

Perhaps the biggest barrier to STI testing is not access or cost but embarrassment. Research consistently shows that perceiving higher levels of stigma around STIs is independently associated with lower odds of getting tested.²² This pattern extends beyond just the testing itself. Some people who test positive decline follow-up treatment because they fear that returning to a clinic or picking up a prescription could lead to disclosure of their diagnosis.²³

Focus group research has identified specific dimensions of how stigma operates: moral judgment from healthcare workers, privacy concerns that keep people away from public clinics, and the fear of being labeled by one’s community.²⁴ These forces are real and powerful, but the infections they protect are treatable, and untreated infections cause complications that are harder to hide than a clinic visit. Home testing kits, telehealth consultations, and mail-order treatment options have all made it possible to manage much of this process privately. The goal is not to eliminate the discomfort entirely but to keep it from being the reason a curable infection becomes a lasting problem.